🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the efficacy, safety, and tolerabi...
Status
Completed
Location
CYS-003 Investigational Site
Start Date
2017-10-19
Trial ID
NCT03292809
Treatments Being Tested
The study aims to determine the effectiveness on the tear film quality and ...
Status
Unknown
Location
Plava Medical Group
Start Date
2023-03-25
Trial ID
NCT05825976
Treatments Being Tested
This is a Phase 2, multi-site, double-masked, randomized, vehicle-controlle...
Status
Completed
Location
GC2302 Study Site 110
Start Date
2025-11-03
Trial ID
NCT07264517
Treatments Being Tested
This study aims at elucidating the mechanism of action of ianalumab in sali...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-07-27
Trial ID
NCT05124925
Treatments Being Tested
The purpose of this post-market clinical follow-up (PMCF) study is to descr...
Status
Active Not Recruiting
Location
Integra Eyecare Centre
Start Date
2026-06-04
Trial ID
NCT07540884
Treatments Being Tested
To evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-27
Trial ID
NCT07737743
Switching to acoltremon 0.003% will significantly improve the signs and sym...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07267299
Treatments Being Tested
Phase 2 study to assess the efficacy of topically administered eyedrops of ...
Status
Completed
Location
iuvo BioScience
Start Date
2024-03-27
Trial ID
NCT06370039
Screening of haitian children between the ages of 3 and 6 years old for amb...
Status
Withdrawn
Location
École Adventiste de Limbé
Start Date
2016-01
Trial ID
NCT02655432
Treatments Being Tested
To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye conta...
Status
Completed
Location
Hazleton Eye Specialists
Start Date
2007-05
Trial ID
NCT00477763
Treatments Being Tested